Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease

Parkinson’s disease (PD) is a neurodegenerative disorder where misfolded alpha-synuclein-enriched aggregates called Lewy bodies are central in pathogenesis. No neuroprotective or disease-modifying treatments are currently available. Parkinson’s disease is considered a multifactorial disease and evid...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallin, Johan, Svenningsson, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198163/
https://www.ncbi.nlm.nih.gov/pubmed/34070609
http://dx.doi.org/10.3390/ijms22115606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198163/
https://www.ncbi.nlm.nih.gov/pubmed/34070609
http://dx.doi.org/10.3390/ijms22115606

Ejemplares similares